124 related articles for article (PubMed ID: 8084608)
21. Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.
Jung JM; Li H; Kobayashi T; Kyritsis AP; Langford LA; Bruner JM; Levin VA; Zhang W
Cell Growth Differ; 1995 Aug; 6(8):909-13. PubMed ID: 8547219
[TBL] [Abstract][Full Text] [Related]
22. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
el-Deiry WS; Harper JW; O'Connor PM; Velculescu VE; Canman CE; Jackman J; Pietenpol JA; Burrell M; Hill DE; Wang Y
Cancer Res; 1994 Mar; 54(5):1169-74. PubMed ID: 8118801
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the p53 gene in primary human breast cancers.
Osborne RJ; Merlo GR; Mitsudomi T; Venesio T; Liscia DS; Cappa AP; Chiba I; Takahashi T; Nau MM; Callahan R
Cancer Res; 1991 Nov; 51(22):6194-8. PubMed ID: 1682043
[TBL] [Abstract][Full Text] [Related]
24. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
25. Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis.
Katayose D; Wersto R; Cowan KH; Seth P
Cell Growth Differ; 1995 Oct; 6(10):1207-12. PubMed ID: 8845297
[TBL] [Abstract][Full Text] [Related]
26. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
Furihata M; Takeuchi T; Matsumoto M; Kurabayashi A; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
Clin Cancer Res; 2002 May; 8(5):1192-5. PubMed ID: 12006537
[TBL] [Abstract][Full Text] [Related]
27. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.
Hübinger G; Müller E; Scheffrahn I; Schneider C; Hildt E; Singer BB; Sigg I; Graf J; Bergmann L
Oncogene; 2001 Feb; 20(5):590-8. PubMed ID: 11313991
[TBL] [Abstract][Full Text] [Related]
28. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
Le NT; Richardson DR
Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
[TBL] [Abstract][Full Text] [Related]
29. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
30. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
31. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
Weinberg WC; Montano NE; Deng C
Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
[TBL] [Abstract][Full Text] [Related]
32. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
[TBL] [Abstract][Full Text] [Related]
33. p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.
Mousses S; Gokgoz N; Wunder JS; Ozcelik H; Bull S; Bell RS; Andrulis IL
Br J Cancer; 2001 Jun; 84(12):1635-9. PubMed ID: 11401317
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
35. Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas.
Malkowicz SB; Tomaszewski JE; Linnenbach AJ; Cangiano TA; Maruta Y; McGarvey TW
Oncogene; 1996 Nov; 13(9):1831-7. PubMed ID: 8934528
[TBL] [Abstract][Full Text] [Related]
36. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
Hui AM; Kanai Y; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1997 Mar; 25(3):575-9. PubMed ID: 9049201
[TBL] [Abstract][Full Text] [Related]
37. WAF1 genotype and endometrial cancer susceptibility.
Hachiya T; Kuriaki Y; Ueoka Y; Nishida J; Kato K; Wake N
Gynecol Oncol; 1999 Feb; 72(2):187-92. PubMed ID: 10021299
[TBL] [Abstract][Full Text] [Related]
38. p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis.
Hsieh YY; Tsai FJ; Chang CC; Chen WC; Tsai CH; Tsai HD; Lin CC
J Clin Lab Anal; 2001; 15(4):184-7. PubMed ID: 11436200
[TBL] [Abstract][Full Text] [Related]
39. Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene.
Mazars GR; Jeanteur P; Lynch HT; Lenoir G; Theillet C
Oncogene; 1992 Apr; 7(4):781-2. PubMed ID: 1565474
[TBL] [Abstract][Full Text] [Related]
40. No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.
Sun Y; Hildesheim A; Li H; Li Y; Chen JY; Cheng YJ; Hayes RB; Rothman N; Bi WF; Cao Y
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):261-7. PubMed ID: 7606201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
